Myles Brown
Myles Brown
Emil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School
Patvirtintas el. paštas - Pagrindinis puslapis
Model-based analysis of ChIP-Seq (MACS)
Y Zhang, T Liu, CA Meyer, J Eeckhoute, DS Johnson, BE Bernstein, ...
Genome biology 9, 1-9, 2008
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ...
Nature medicine 24 (10), 1550-1558, 2018
Cofactor dynamics and sufficiency in estrogen receptor–regulated transcription
Y Shang, X Hu, J DiRenzo, MA Lazar, M Brown
Cell 103 (6), 843-852, 2000
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
W Li, H Xu, T Xiao, L Cong, MI Love, F Zhang, RA Irizarry, JS Liu, ...
Genome biology 15, 1-12, 2014
Genome-wide analysis of estrogen receptor binding sites
JS Carroll, CA Meyer, J Song, W Li, TR Geistlinger, J Eeckhoute, ...
Nature genetics 38 (11), 1289-1297, 2006
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll, XS Liu, AS Brodsky, W Li, CA Meyer, AJ Szary, J Eeckhoute, ...
Cell 122 (1), 33-43, 2005
Molecular determinants for the tissue specificity of SERMs
Y Shang, M Brown
Science 295 (5564), 2465-2468, 2002
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
M Lupien, J Eeckhoute, CA Meyer, Q Wang, Y Zhang, W Li, JS Carroll, ...
Cell 132 (6), 958-970, 2008
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
E Giovannucci, MJ Stampfer, K Krithivas, M Brown, A Brufsky, J Talcott, ...
Proceedings of the National Academy of Sciences 94 (7), 3320-3323, 1997
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ...
Cell 138 (2), 245-256, 2009
X chromosomal abnormalities in basal-like human breast cancer
AL Richardson, ZC Wang, A De Nicolo, X Lu, M Brown, A Miron, X Liao, ...
Cancer cell 9 (2), 121-132, 2006
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent
K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ...
Science 338 (6113), 1465-1469, 2012
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
SY Ku, S Rosario, Y Wang, P Mu, M Seshadri, ZW Goodrich, ...
Science 355 (6320), 78-83, 2017
Differential activation of peroxisome proliferator-activated receptors by eicosanoids (∗)
K Yu, W Bayona, CB Kallen, HP Harding, CP Ravera, G McMahon, ...
Journal of Biological Chemistry 270 (41), 23975-23983, 1995
Formation of the androgen receptor transcription complex
Y Shang, M Myers, M Brown
Molecular cell 9 (3), 601-610, 2002
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
X Chen, D Iliopoulos, Q Zhang, Q Tang, MB Greenblatt, M Hatziapostolou, ...
Nature 508 (7494), 103-107, 2014
Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription
S Halachmi, E Marden, G Martin, H MacKay, C Abbondanza, M Brown
Science 264 (5164), 1455-1458, 1994
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth
Q Wang, W Li, XS Liu, JS Carroll, OA Jänne, EK Keeton, AM Chinnaiyan, ...
Molecular cell 27 (3), 380-392, 2007
Cistrome: an integrative platform for transcriptional regulation studies
T Liu, JA Ortiz, L Taing, CA Meyer, B Lee, Y Zhang, H Shin, SS Wong, ...
Genome biology 12, 1-10, 2011
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
D Pan, A Kobayashi, P Jiang, L Ferrari de Andrade, RE Tay, AM Luoma, ...
Science 359 (6377), 770-775, 2018
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20